[ET Net News Agency, 10 July 2026] HANSOH PHARMA (03692) rose 4.9% to HK$32.68.
It hits an intra-day high of HK$32.72, breaking above the 50-D SMA of HK$32.364, and an intra-day low of HK$30.86. The total shares traded was 4.67 million, with a value of HK$149.39m. The active buy/sell ratio is 66:34, with net buying turnover of HK$40.88m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$10.91m, with volume weighted average price of HK$32.326. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$18.1m, with volume weighted average price of HK$31.948.
The Hang Seng Index now rose 458 points, or 1.9% to 24,488; the Hang Seng China Enterprises Index now rose 146 points, or 1.8% to 8,144.
Basic Information| Nominal | 32.680 | % Chg | +4.88% |
| High | 32.720 | Low | 30.860 |
| Shares Tr | 4.67m | Turnover | 149.39m |
| 10-D SMA | 31.556 | %H.V | 48.001 |
| 20-D SMA | 30.453 | VWAP | 31.962 |
| 50-D SMA | 32.364 | RSI14 | 56.670 |
Status: Breaking above the 50-D SMA, active buy/sell ratio is 66:34, with net buying turnover of HK$40.88m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 32.68 | +4.88 |
| SIHUAN PHARM (00460) | 0.86 | +3.61 |
| GRAND PHARMA (00512) | 5.19 | +1.76 |
| SBP GROUP (01177) | 5.29 | +5.80 |
| HENGRUI PHARMA (01276) | 61.10 | +4.44 |
| LIVZON PHARMA (01513) | 25.84 | +2.22 |
| LUYE PHARMA (02186) | 1.94 | +1.57 |
| FOSUN PHARMA (02196) | 16.48 | +3.19 |
| SH PHARMA (02607) | 11.74 | +0.09 |
| CHINARES PHARMA (03320) | 4.51 | +1.58 |
(ed)
